secwatch.observer — SEC 8-K summary
======================================

Issuer:     SI-BONE, Inc. (SIBN)
CIK:        0001459839
Form:       8-K
Filed at:   2022-11-07T23:59:59+00:00
Accession:  0001459839-22-000042
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SI-BONE posts Q3 2022 record revenue of $26.4M, up 19% YoY; guides FY22 revenue $104-105M
--------------------------------------------------------------------------------

- Worldwide revenue $26.4M (+19% YoY); U.S. revenue $24.6M (+21% YoY).
- Gross margin 84% vs 89% YoY, pressured by product mix, lower ASPs, and higher freight.
- Net loss $14.2M ($0.41/share) vs $15.9M ($0.48/share) in prior year.
- FY2022 revenue guidance raised to $104-105M (16-17% growth); implies Q4 of $29.5-30.5M.
- Over 800 U.S. active surgeons (+27% YoY); CMS finalized ~26-33% Medicare facility fee hike for 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1459839/000145983922000042/0001459839-22-000042-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1459839/000145983922000042/sibn-20221107.htm
  HTML page:      https://secwatch.observer/filing/0001459839-22-000042

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer